Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

By Dania Nadeem and Carl O'Donnell

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Thomson Reuters 2021.

©2021 GPlusMedia Inc.

Login to comment

Nobody can say with certainty that these experimental vaccines are safe.

The long term data simply doesn’t exist

-3 ( +0 / -3 )

Another tool in the war against COVID. Excellent.

2 ( +2 / -0 )

Final results from the Novavax trial provide further hope as daily COVID-19 deaths spike in Britain, likely driven by the UK variant.

Spiking? Death rates are declining in the UK, due to the the lockdown and vaccine rollout.

0 ( +0 / -0 )

Great. I can't wait until it's approved in Japan... several years from now.

1 ( +1 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites